TGA rules psychedelics should remain prohibited
A mental health charity backing therapeutic use of the drugs warns patients will ‘go underground’
The TGA has rejected a bid to down-schedule psychedelic substances psilocybin and MDMA (ecstasy), which would have allowed patients with psychiatric disorders greater access to the drugs.
Charity and lobby group Mind Medicine Australia made the application in July 2020, requesting the substances be classed as controlled drugs (S8) for clinical use by psychiatrists and addiction specialists rather than prohibited substances (S9).
